M2PHARMA-March 8, 2012-Lilly and Boehringer Ingelheim announce availability of Jentadueto in US pharmacies (C)2012 M2 COMMUNICATIONS http://www.m2.com
Pharmaceutical product corporation Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim Pharmaceuticals Inc announced on Wednesday that Jentadueto (linagliptin/metformin hydrochloride) tablets are now available by prescription in several leading chain and independent pharmacies across the US.
Jentadueto is a new prescription medication for patients who need to control their blood sugar.
Linagliptin is marketed in the US as Tradjenta 5mg once-daily tablets. Jentadueto was approved …